Delivery Order SPE2DB22D1017-SPE2DB24FF7QV

Award Date 5/14/24
Potential Completion Date 5/15/24
Potential Value $3.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order valued at $3,631.38 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. This order is part of a larger indefinite delivery contract (IDC) worth up to $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies in support of...
The U.S. Defense Logistics Agency (DLA) awarded a $14,143.79 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml pharmaceuticals. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml pharmaceutical products. The contract has a completion date of February 8, 2024 and a potential value of $1,161.08. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with a set-aside designation. This...
The Defense Logistics Agency (DLA) awarded a delivery order to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml. This $2,633.57 firm fixed price contract has an ultimate completion date of August 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract (SPE2DX15D3404|SPE2DX24F1ARH) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $18,333.87 contract is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a specialty pharmaceutical product. This delivery order is part of Amerisourcebergen Drug Corp's broader indefinite...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $11,026.45 contract is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. This delivery order is part of a larger, single award indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA Troop Support Medical...
The Defense Logistics Agency (DLA) awarded a delivery order contract worth $2,304.52 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. This contract has an ultimate completion date of April 16, 2024 and is a firm fixed price delivery order. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. The order, valued at $15,285.04, has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $4,644.32 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $7,118.58 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. This order is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a diabetes medication. The delivery order has a completion date of February 6, 2024 and was awarded on February 5, 2024. This award is part of Amerisourcebergen Drug Corp's broader indefinite delivery contract (IDC) with...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FF7QV
    Delivery Order

The Defense Logistics Agency (DLA) awarded a $3,287.16 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml pharmaceutical product. The contract has an ultimate completion date of May 15, 2024. Amerisourcebergen Drug Corp holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This specific delivery order is not designated as a set-aside contract.

Generated 8/13/24, 11:31 AM